Science Explorer Interactive view Map
Research facility · Boulogne-Billancourt · France

Biomarqueurs et essais cliniques en Cancérologie et Onco-Hématologie

uvsq.fr/biomarqueurs-et-essais-cliniques-en-cancerologie-et-onco-hematologie-beccoh-ur-4340ROR OpenAlex
Research works
9
▲ 1003% vs 2013–17
Citations
77
8.6 per fractional work
Top-10% rate
13.0%
record average 16.5%
Open access
63%
world 28%

Not ranked overall: Biomarqueurs et essais cliniques en Cancérologie et Onco-Hématologie is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Which research topics does Biomarqueurs et essais cliniques en Cancérologie et Onco-Hématologie publish most on?

By volume in 2022–2025: Histiocytic Disorders and Treatments, Cancer Immunotherapy and Biomarkers, Tuberous Sclerosis Complex Research and Colorectal Cancer Treatments and Studies.

Histiocytic Disorders an…1Histiocytic Disorders and Treatments: 1 fractional worksCancer Immunotherapy and…1Cancer Immunotherapy and Biomarkers: 1 fractional worksTuberous Sclerosis Complex Research: 0 fractional worksColorectal Cancer Treatments and Studies: 0 fractional worksImmune cells in cancer: 0 fractional worksGenetic and rare skin di…0Genetic and rare skin diseases.: 0 fractional worksHepatocellular Carcinoma Treatment and Prognosis: 0 fractional worksGenital Health and Disease: 0 fractional worksLung Cancer Research Studies: 0 fractional worksCAR-T cell therapy research: 0 fractional works
PhysiologyOncologyImmunologyGenetics2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Histiocytic Disorders and Treatments Physiology 1 works
  2. 2 Cancer Immunotherapy and Biomarkers Oncology 1 works
  3. 3 Tuberous Sclerosis Complex Research Physiology 0 works
  4. 4 Colorectal Cancer Treatments and Studies Oncology 0 works
  5. 5 Immune cells in cancer Immunology 0 works
  6. 6 Genetic and rare skin diseases. Genetics 0 works
  7. 7 Hepatocellular Carcinoma Treatment and Prognosis Hepatology 0 works
  8. 8 Genital Health and Disease Surgery 0 works
  9. 9 Lung Cancer Research Studies Oncology 0 works
  10. 10 CAR-T cell therapy research Oncology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available62.8%not open37.2%

World: 28% of research is openly available.

with international co-authors35.0%domestic only65.0%

World: 19% is written across borders.

How has Biomarqueurs et essais cliniques en Cancérologie et Onco-Hématologie's research output changed?

Output in 2018–2022 was 1003% higher than in 2013–2017.

201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Boulogne-Billancourt

All research institutions in Boulogne-Billancourt

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.